Alliance Global lowered the firm’s price target on Tenon Medical (TNON) to $2.50 from $2.75 and keeps a Buy rating on the shares. The firm’s revised target reflects lower forecasts following the company’s Q3 report.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNON:
- Tenon Medical Reports Q3 2025 Financial Results
- Tenon Medical prices 2.2M shares at $1.285 in PIPE financing
- Tenon Medical, Inc. (TNON) Q3 Earnings Cheat Sheet
- Strategic Acquisitions and Product Innovations Drive Buy Rating for Tenon Medical, Inc.
- Tenon Medical announces 510(k) clearance for SImmerty+ SI Joint Fusion System